regulation of transport (GO:0051049) | 2.24 | 14 | CACNA1C, AKAP9, SCN5A, CALM1, ANK2, KCNQ1, KCNE1, KCNH2, KCNE2, KCNJ2, CAV3, KCNJ5, SCN4B, SNTA1 |
biological regulation (GO:0065007) | 0.39 | 14 | AKAP9, CACNA1C, SCN5A, CALM1, ANK2, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, KCNJ5, KCNE1, SNTA1, SCN4B |
single-organism process (GO:0044699) | 0.48 | 14 | AKAP9, CACNA1C, SCN5A, CALM1, ANK2, ALG10, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, KCNJ5, KCNE1, SCN4B |
regulation of ion transport (GO:0043269) | 3.4 | 14 | CACNA1C, AKAP9, SCN5A, KCNE1, ANK2, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, KCNJ5, CALM1, SCN4B, SNTA1 |
regulation of ion transmembrane transport (GO:0034765) | 3.77 | 14 | CACNA1C, AKAP9, SCN5A, CALM1, ANK2, KCNH2, KCNE1, KCNQ1, KCNE2, KCNJ2, CAV3, KCNJ5, SCN4B, SNTA1 |
regulation of localization (GO:0032879) | 1.94 | 14 | CACNA1C, AKAP9, SCN5A, SCN4B, ANK2, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, KCNJ5, CALM1, KCNE1, SNTA1 |
regulation of biological process (GO:0050789) | 0.45 | 14 | CACNA1C, AKAP9, SCN5A, KCNE1, ANK2, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, KCNJ5, CALM1, SCN4B, SNTA1 |
regulation of transmembrane transport (GO:0034762) | 3.74 | 14 | CACNA1C, AKAP9, SCN5A, CALM1, ANK2, KCNQ1, KCNE1, KCNH2, KCNE2, KCNJ2, CAV3, KCNJ5, SCN4B, SNTA1 |
multicellular organismal process (GO:0032501) | 1.45 | 13 | CACNA1C, AKAP9, SCN5A, KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, ANK2, CALM1, SCN4B, SNTA1 |
regulation of biological quality (GO:0065008) | 1.68 | 13 | CACNA1C, AKAP9, SCN5A, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, ANK2, CALM1, KCNE1, SNTA1, SCN4B |
regulation of system process (GO:0044057) | 3.53 | 13 | CACNA1C, AKAP9, SCN5A, KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, ANK2, CALM1, SCN4B, SNTA1 |
transport (GO:0006810) | 1.51 | 13 | CALM1, AKAP9, SCN5A, SCN4B, ANK2, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, KCNJ5, KCNE1, CACNA1C |
regulation of cation transmembrane transport (GO:1904062) | 4.4 | 13 | CACNA1C, AKAP9, SCN5A, KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, ANK2, CALM1, SCN4B, SNTA1 |
regulation of heart contraction (GO:0008016) | 4.35 | 13 | AKAP9, CACNA1C, SCN5A, CALM1, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, ANK2, KCNE1, SNTA1, SCN4B |
regulation of metal ion transport (GO:0010959) | 3.94 | 13 | CACNA1C, AKAP9, SCN5A, CALM1, KCNH2, KCNQ1, KCNE2, KCNJ2, CAV3, ANK2, KCNE1, SNTA1, SCN4B |
regulation of heart rate (GO:0002027) | 5.29 | 13 | AKAP9, CACNA1C, SCN5A, CALM1, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, ANK2, KCNE1, SNTA1, SCN4B |
single-organism cellular process (GO:0044763) | 0.65 | 13 | CACNA1C, AKAP9, SCN5A, CALM1, ANK2, ALG10, KCNH2, KCNQ1, KCNE2, KCNJ2, CAV3, KCNJ5, KCNE1 |
regulation of multicellular organismal process (GO:0051239) | 1.87 | 13 | CACNA1C, AKAP9, SCN5A, KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, ANK2, CALM1, SCN4B, SNTA1 |
regulation of blood circulation (GO:1903522) | 4.05 | 13 | CALM1, AKAP9, SCN5A, SCN4B, KCNQ1, KCNH2, CACNA1C, KCNE2, KCNJ2, CAV3, ANK2, KCNE1, SNTA1 |
cellular process (GO:0009987) | 0.26 | 13 | CACNA1C, AKAP9, SCN5A, KCNE1, ANK2, ALG10, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, KCNJ5, CALM1 |
establishment of localization (GO:0051234) | 1.48 | 13 | AKAP9, CACNA1C, SCN5A, CALM1, ANK2, KCNQ1, KCNE1, KCNH2, KCNE2, KCNJ2, CAV3, KCNJ5, SCN4B |
localization (GO:0051179) | 1.4 | 13 | AKAP9, CACNA1C, SCN5A, CALM1, ANK2, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, KCNJ5, KCNE1, SCN4B |
regulation of membrane potential (GO:0042391) | 3.89 | 12 | CACNA1C, AKAP9, SCN5A, SCN4B, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, ANK2, KCNE1, SNTA1 |
regulation of cellular process (GO:0050794) | 0.5 | 12 | CACNA1C, AKAP9, SCN5A, KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, ANK2, CALM1, SNTA1 |
cardiac muscle cell action potential (GO:0086001) | 6.33 | 11 | CACNA1C, KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, ANK2, SCN5A, SNTA1, SCN4B |
cardiac muscle cell action potential involved in contraction (GO:0086002) | 6.47 | 11 | CACNA1C, KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, ANK2, SCN5A, SNTA1, SCN4B |
positive regulation of transport (GO:0051050) | 2.9 | 11 | AKAP9, SCN5A, KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, ANK2, CALM1, SCN4B |
ion transport (GO:0006811) | 2.66 | 11 | CACNA1C, SCN5A, SCN4B, ANK2, KCNQ1, KCNH2, KCNE2, KCNJ2, KCNJ5, CALM1, KCNE1 |
regulation of membrane repolarization (GO:0060306) | 6.4 | 11 | AKAP9, SCN5A, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, ANK2, KCNE1, SNTA1, SCN4B |
positive regulation of biological process (GO:0048518) | 1.2 | 11 | AKAP9, SCN5A, CALM1, KCNQ1, KCNE1, KCNH2, KCNE2, KCNJ2, CAV3, ANK2, SCN4B |
action potential (GO:0001508) | 5.42 | 11 | CACNA1C, KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, ANK2, SCN5A, SNTA1, SCN4B |
single organism signaling (GO:0044700) | 3.25 | 10 | CACNA1C, AKAP9, SCN5A, KCNH2, KCNQ1, KCNE2, KCNJ2, ANK2, KCNE1, SCN4B |
cardiac conduction (GO:0061337) | 5.54 | 10 | CACNA1C, AKAP9, KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, ANK2, SCN5A, SCN4B |
single-multicellular organism process (GO:0044707) | 1.78 | 10 | CACNA1C, AKAP9, KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, ANK2, SCN5A, SCN4B |
cation transport (GO:0006812) | 3.11 | 10 | CACNA1C, KCNE1, ANK2, KCNQ1, KCNH2, KCNE2, KCNJ2, KCNJ5, SCN5A, SCN4B |
response to stimulus (GO:0050896) | 1.22 | 10 | AKAP9, SCN5A, KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, ANK2, CALM1 |
regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 6.84 | 10 | AKAP9, SCN5A, KCNQ1, KCNH2, KCNE2, CAV3, ANK2, KCNE1, SNTA1, SCN4B |
regulation of heart rate by cardiac conduction (GO:0086091) | 6.33 | 10 | CACNA1C, AKAP9, SCN5A, SCN4B, KCNQ1, KCNH2, KCNE2, KCNJ2, ANK2, KCNE1 |
positive regulation of ion transport (GO:0043270) | 4.36 | 10 | AKAP9, SCN5A, KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, ANK2, CALM1, SCN4B |
ion transmembrane transport (GO:0034220) | 3.08 | 10 | CACNA1C, SCN5A, CALM1, KCNH2, KCNQ1, KCNE2, KCNJ2, KCNJ5, KCNE1, SCN4B |
single-organism transport (GO:0044765) | 2.18 | 10 | CACNA1C, CALM1, ANK2, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, KCNJ5, KCNE1 |
regulation of cardiac muscle cell membrane repolarization (GO:0099623) | 6.68 | 10 | AKAP9, KCNE1, KCNQ1, KCNH2, KCNE2, CAV3, ANK2, SCN5A, SNTA1, SCN4B |
signaling (GO:0023052) | 3.25 | 10 | CACNA1C, AKAP9, SCN5A, KCNQ1, KCNH2, KCNE2, KCNJ2, ANK2, KCNE1, SCN4B |
metal ion transport (GO:0030001) | 3.36 | 10 | CACNA1C, SCN5A, KCNE1, ANK2, KCNQ1, KCNH2, KCNE2, KCNJ2, KCNJ5, SCN4B |
multicellular organismal signaling (GO:0035637) | 5.36 | 10 | CACNA1C, AKAP9, SCN5A, KCNQ1, KCNH2, KCNE2, KCNJ2, ANK2, KCNE1, SCN4B |
transmembrane transport (GO:0055085) | 2.72 | 10 | CACNA1C, SCN5A, CALM1, KCNH2, KCNQ1, KCNE2, KCNJ2, KCNJ5, KCNE1, SCN4B |
single-organism localization (GO:1902578) | 2.09 | 10 | CACNA1C, CALM1, ANK2, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, KCNJ5, KCNE1 |
positive regulation of cellular process (GO:0048522) | 1.3 | 10 | AKAP9, SCN5A, KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, ANK2, CALM1 |
cation transmembrane transport (GO:0098655) | 3.43 | 9 | CACNA1C, SCN5A, SCN4B, KCNQ1, KCNH2, KCNE2, KCNJ2, KCNJ5, KCNE1 |
inorganic ion transmembrane transport (GO:0098660) | 3.38 | 9 | CACNA1C, KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, KCNJ5, SCN5A, SCN4B |
inorganic cation transmembrane transport (GO:0098662) | 3.55 | 9 | CACNA1C, SCN5A, KCNH2, KCNQ1, KCNE2, KCNJ2, KCNJ5, KCNE1, SCN4B |
system process (GO:0003008) | 2.3 | 9 | SCN5A, CALM1, KCNH2, KCNQ1, CAV3, KCNJ2, KCNE1, SNTA1, SCN4B |
ventricular cardiac muscle cell action potential (GO:0086005) | 7.02 | 8 | KCNE1, KCNH2, KCNQ1, KCNE2, CAV3, ANK2, SCN5A, SNTA1 |
regulation of ion transmembrane transporter activity (GO:0032412) | 4.55 | 8 | AKAP9, CALM1, KCNQ1, KCNE2, CAV3, ANK2, KCNE1, SCN4B |
regulation of transmembrane transporter activity (GO:0022898) | 4.52 | 8 | AKAP9, CALM1, KCNQ1, KCNE2, CAV3, ANK2, KCNE1, SCN4B |
positive regulation of cation transmembrane transport (GO:1904064) | 5.17 | 8 | AKAP9, CALM1, KCNQ1, KCNH2, KCNE2, KCNJ2, ANK2, KCNE1 |
regulation of transporter activity (GO:0032409) | 4.45 | 8 | AKAP9, CALM1, KCNQ1, KCNE2, CAV3, ANK2, KCNE1, SCN4B |
regulation of potassium ion transport (GO:0043266) | 5.31 | 8 | AKAP9, KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, ANK2 |
muscle system process (GO:0003012) | 4.18 | 8 | CALM1, KCNH2, KCNQ1, CAV3, KCNJ2, SCN5A, SNTA1, SCN4B |
regulation of potassium ion transmembrane transport (GO:1901379) | 5.62 | 8 | AKAP9, KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, CAV3, ANK2 |
positive regulation of transmembrane transport (GO:0034764) | 4.99 | 8 | AKAP9, KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, ANK2, CALM1 |
response to chemical (GO:0042221) | 1.98 | 8 | AKAP9, SCN5A, CALM1, KCNH2, KCNQ1, KCNE2, ANK2, KCNE1 |
regulation of molecular function (GO:0065009) | 1.78 | 8 | AKAP9, CALM1, KCNQ1, KCNE2, CAV3, ANK2, KCNE1, SCN4B |
positive regulation of ion transmembrane transport (GO:0034767) | 5.05 | 8 | AKAP9, CALM1, KCNQ1, KCNH2, KCNE2, KCNJ2, ANK2, KCNE1 |
monovalent inorganic cation transport (GO:0015672) | 3.74 | 8 | KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, KCNJ5, SCN5A, SCN4B |
developmental process (GO:0032502) | 1.36 | 7 | CACNA1C, SCN5A, KCNQ1, KCNE2, CAV3, ANK2, CALM1 |
primary metabolic process (GO:0044238) | 0.69 | 7 | AKAP9, CALM1, ALG10, KCNQ1, KCNH2, CAV3, KCNE1 |
cellular response to stimulus (GO:0051716) | 1.97 | 7 | AKAP9, KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, SCN5A |
muscle contraction (GO:0006936) | 4.37 | 7 | SCN5A, CALM1, KCNQ1, KCNH2, CAV3, SCN4B, SNTA1 |
regulation of metabolic process (GO:0019222) | 1.02 | 7 | AKAP9, CALM1, KCNQ1, KCNE2, CAV3, ANK2, SNTA1 |
regulation of muscle contraction (GO:0006937) | 4.75 | 7 | CACNA1C, SCN5A, KCNQ1, CAV3, KCNJ2, ANK2, CALM1 |
regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 7 | AKAP9, CALM1, KCNQ1, KCNE2, CAV3, ANK2, SNTA1 |
anatomical structure development (GO:0048856) | 1.58 | 7 | CACNA1C, SCN5A, KCNQ1, KCNE2, CAV3, ANK2, CALM1 |
cellular metabolic process (GO:0044237) | 0.69 | 7 | AKAP9, CALM1, ALG10, KCNH2, KCNQ1, CAV3, KCNE1 |
single-organism developmental process (GO:0044767) | 1.49 | 7 | CACNA1C, SCN5A, KCNQ1, KCNE2, CAV3, ANK2, CALM1 |
organic substance metabolic process (GO:0071704) | 0.63 | 7 | AKAP9, CALM1, ALG10, KCNH2, KCNQ1, CAV3, KCNE1 |
regulation of striated muscle contraction (GO:0006942) | 5.38 | 7 | CACNA1C, SCN5A, KCNQ1, CAV3, KCNJ2, ANK2, CALM1 |
regulation of muscle system process (GO:0090257) | 4.51 | 7 | CACNA1C, SCN5A, KCNQ1, CAV3, KCNJ2, ANK2, CALM1 |
metabolic process (GO:0008152) | 0.58 | 7 | AKAP9, CALM1, ALG10, KCNH2, KCNQ1, CAV3, KCNE1 |
negative regulation of biological process (GO:0048519) | 1.33 | 7 | CALM1, KCNQ1, KCNH2, KCNE2, CAV3, KCNE1, SNTA1 |
regulation of cardiac muscle contraction (GO:0055117) | 5.57 | 7 | CACNA1C, SCN5A, KCNQ1, CAV3, KCNJ2, ANK2, CALM1 |
negative regulation of cellular process (GO:0048523) | 1.41 | 7 | CALM1, KCNH2, KCNQ1, KCNE2, CAV3, KCNE1, SNTA1 |
single-organism metabolic process (GO:0044710) | 1.63 | 6 | AKAP9, CALM1, ALG10, KCNH2, CAV3, KCNE1 |
membrane depolarization during action potential (GO:0086010) | 6.07 | 6 | CACNA1C, SCN5A, KCNH2, KCNJ2, ANK2, SCN4B |
cellular macromolecule metabolic process (GO:0044260) | 0.93 | 6 | AKAP9, CALM1, ALG10, KCNH2, CAV3, KCNE1 |
cellular potassium ion transport (GO:0071804) | 4.79 | 6 | KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, KCNJ5 |
potassium ion transmembrane transport (GO:0071805) | 4.79 | 6 | KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, KCNJ5 |
potassium ion transport (GO:0006813) | 4.68 | 6 | KCNE1, KCNQ1, KCNH2, KCNE2, KCNJ2, KCNJ5 |
negative regulation of transport (GO:0051051) | 3.6 | 6 | CALM1, KCNH2, KCNQ1, CAV3, KCNE2, KCNE1 |
negative regulation of cation transmembrane transport (GO:1904063) | 5.65 | 6 | CALM1, KCNH2, KCNQ1, CAV3, KCNE2, KCNE1 |
regulation of potassium ion transmembrane transporter activity (GO:1901016) | 6.02 | 6 | AKAP9, KCNE1, KCNQ1, CAV3, KCNE2, ANK2 |
macromolecule metabolic process (GO:0043170) | 0.83 | 6 | AKAP9, CALM1, ALG10, KCNH2, CAV3, KCNE1 |
negative regulation of ion transport (GO:0043271) | 4.94 | 6 | CALM1, KCNH2, KCNQ1, CAV3, KCNE2, KCNE1 |
membrane depolarization (GO:0051899) | 5.62 | 6 | CACNA1C, SCN4B, KCNH2, KCNJ2, ANK2, SCN5A |
cellular response to chemical stimulus (GO:0070887) | 2.57 | 6 | AKAP9, SCN5A, KCNQ1, KCNH2, KCNE2, KCNE1 |
negative regulation of ion transmembrane transport (GO:0034766) | 5.47 | 6 | CALM1, KCNQ1, KCNH2, CAV3, KCNE2, KCNE1 |
negative regulation of transmembrane transport (GO:0034763) | 5.38 | 6 | CALM1, KCNH2, KCNQ1, CAV3, KCNE2, KCNE1 |
positive regulation of potassium ion transmembrane transport (GO:1901381) | 6.43 | 6 | AKAP9, KCNE1, KCNQ1, KCNH2, KCNJ2, ANK2 |
positive regulation of potassium ion transport (GO:0043268) | 6.09 | 6 | AKAP9, KCNE1, KCNQ1, KCNH2, KCNJ2, ANK2 |
negative regulation of transporter activity (GO:0032410) | 5.59 | 5 | CALM1, KCNQ1, KCNE1, CAV3, KCNE2 |
positive regulation of metabolic process (GO:0009893) | 1.74 | 5 | AKAP9, CAV3, CALM1, ANK2, KCNE2 |
regulation of cellular localization (GO:0060341) | 3.03 | 5 | CACNA1C, CALM1, KCNE1, CAV3, ANK2 |
negative regulation of ion transmembrane transporter activity (GO:0032413) | 5.74 | 5 | KCNQ1, CALM1, KCNE1, CAV3, KCNE2 |
ion homeostasis (GO:0050801) | 3.42 | 5 | KCNJ2, CACNA1C, KCNH2, CAV3, ANK2 |
regulation of cellular metabolic process (GO:0031323) | 1.07 | 5 | AKAP9, SNTA1, CALM1, CAV3, KCNE2 |
regulation of homeostatic process (GO:0032844) | 3.65 | 5 | CACNA1C, CALM1, SCN5A, CAV3, ANK2 |
homeostatic process (GO:0042592) | 2.61 | 5 | KCNJ2, CACNA1C, KCNH2, CAV3, ANK2 |
membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 7.43 | 5 | KCNJ2, KCNQ1, KCNE1, KCNE2, KCNH2 |
signal transduction (GO:0007165) | 1.28 | 5 | CACNA1C, AKAP9, KCNH2, ANK2, CALM1 |
regulation of signaling (GO:0023051) | 1.72 | 5 | CACNA1C, CAV3, CALM1, ANK2, KCNE2 |
inorganic ion homeostasis (GO:0098771) | 3.43 | 5 | KCNJ2, CACNA1C, KCNH2, CAV3, ANK2 |
intracellular signal transduction (GO:0035556) | 2.39 | 5 | CACNA1C, AKAP9, KCNH2, ANK2, CALM1 |
regulation of cell communication (GO:0010646) | 1.73 | 5 | CACNA1C, CAV3, CALM1, ANK2, KCNE2 |
regulation of primary metabolic process (GO:0080090) | 1.08 | 5 | AKAP9, SNTA1, CALM1, CAV3, KCNE2 |
cellular protein metabolic process (GO:0044267) | 1.63 | 5 | AKAP9, KCNE1, CALM1, ALG10, KCNH2 |
positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 5 | AKAP9, CAV3, CALM1, ANK2, KCNE2 |
regulation of protein metabolic process (GO:0051246) | 1.93 | 5 | AKAP9, SNTA1, CALM1, CAV3, KCNE2 |
membrane repolarization (GO:0086009) | 7.02 | 5 | KCNJ2, KCNQ1, KCNE1, KCNE2, KCNH2 |
regulation of action potential (GO:0098900) | 6.07 | 5 | KCNJ2, CACNA1C, SCN5A, CAV3, ANK2 |
negative regulation of molecular function (GO:0044092) | 2.74 | 5 | CALM1, KCNQ1, KCNE1, CAV3, KCNE2 |
negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.68 | 5 | KCNQ1, KCNH2, KCNE1, CAV3, KCNE2 |
regulation of actin filament-based process (GO:0032970) | 3.97 | 5 | KCNJ2, CACNA1C, SCN5A, CAV3, ANK2 |
cellular protein modification process (GO:0006464) | 1.79 | 5 | AKAP9, KCNE1, CALM1, ALG10, KCNH2 |
macromolecule modification (GO:0043412) | 1.73 | 5 | AKAP9, KCNE1, CALM1, ALG10, KCNH2 |
protein modification process (GO:0036211) | 1.79 | 5 | AKAP9, KCNE1, CALM1, ALG10, KCNH2 |
metal ion homeostasis (GO:0055065) | 3.61 | 5 | KCNJ2, CACNA1C, KCNH2, CAV3, ANK2 |
cation homeostasis (GO:0055080) | 3.46 | 5 | KCNJ2, CACNA1C, KCNH2, CAV3, ANK2 |
membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 7.09 | 5 | CACNA1C, SCN4B, SCN5A, KCNJ2, ANK2 |
membrane repolarization during action potential (GO:0086011) | 7.43 | 5 | KCNJ2, KCNH2, KCNE1, KCNE2, KCNQ1 |
regulation of calcium ion transmembrane transport (GO:1903169) | 4.98 | 5 | CACNA1C, CAV3, CALM1, ANK2, KCNE2 |
response to organic substance (GO:0010033) | 2.2 | 5 | AKAP9, KCNQ1, KCNE1, ANK2, CALM1 |
negative regulation of potassium ion transport (GO:0043267) | 6.26 | 5 | KCNQ1, KCNE1, CAV3, KCNE2, KCNH2 |
regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 5 | AKAP9, SNTA1, CALM1, CAV3, KCNE2 |
protein metabolic process (GO:0019538) | 1.45 | 5 | AKAP9, KCNE1, CALM1, ALG10, KCNH2 |
regulation of calcium ion transport (GO:0051924) | 4.38 | 5 | CACNA1C, CAV3, CALM1, ANK2, KCNE2 |
chemical homeostasis (GO:0048878) | 2.97 | 5 | KCNJ2, CACNA1C, KCNH2, CAV3, ANK2 |
cardiac muscle cell membrane repolarization (GO:0099622) | 7.43 | 5 | KCNJ2, KCNQ1, KCNE1, KCNE2, KCNH2 |
regulation of ion homeostasis (GO:2000021) | 4.44 | 5 | CACNA1C, CALM1, SCN5A, CAV3, ANK2 |
regulation of cation channel activity (GO:2001257) | 5.27 | 5 | KCNQ1, KCNE1, CALM1, ANK2, KCNE2 |
positive regulation of ion transmembrane transporter activity (GO:0032414) | 5.55 | 4 | AKAP9, CALM1, ANK2, KCNE2 |
cellular homeostasis (GO:0019725) | 3.23 | 4 | KCNJ2, CACNA1C, CAV3, ANK2 |
negative regulation of metabolic process (GO:0009892) | 1.93 | 4 | CALM1, SNTA1, KCNQ1, CAV3 |
positive regulation of transporter activity (GO:0032411) | 5.44 | 4 | AKAP9, CALM1, ANK2, KCNE2 |
positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 4 | AKAP9, CALM1, CAV3, KCNE2 |
regulation of response to stimulus (GO:0048583) | 1.54 | 4 | KCNQ1, CALM1, CAV3, KCNE2 |
striated muscle contraction (GO:0006941) | 5.37 | 4 | KCNQ1, KCNH2, SCN5A, SCN4B |
cardiac muscle contraction (GO:0060048) | 5.88 | 4 | KCNQ1, KCNH2, SCN5A, SCN4B |
cellular component organization or biogenesis (GO:0071840) | 1.22 | 4 | KCNJ2, AKAP9, CAV3, ANK2 |
response to endogenous stimulus (GO:0009719) | 2.79 | 4 | AKAP9, CALM1, KCNE1, KCNQ1 |
potassium ion export (GO:0071435) | 7.43 | 4 | KCNQ1, KCNH2, KCNE1, KCNE2 |
negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 4 | CALM1, SNTA1, KCNQ1, CAV3 |
positive regulation of protein metabolic process (GO:0051247) | 2.43 | 4 | AKAP9, CALM1, CAV3, KCNE2 |
cellular component organization (GO:0016043) | 1.24 | 4 | KCNJ2, AKAP9, CAV3, ANK2 |
positive regulation of cellular protein metabolic process (GO:0032270) | 2.49 | 4 | AKAP9, CALM1, CAV3, KCNE2 |
response to organic cyclic compound (GO:0014070) | 3.07 | 4 | AKAP9, CALM1, KCNE1, KCNQ1 |
positive regulation of molecular function (GO:0044093) | 2.23 | 4 | AKAP9, CALM1, ANK2, KCNE2 |
regulation of protein modification process (GO:0031399) | 2.32 | 4 | AKAP9, SNTA1, CALM1, CAV3 |
regulation of sodium ion transport (GO:0002028) | 5.4 | 4 | SCN5A, SNTA1, SCN4B, CAV3 |
regulation of sodium ion transmembrane transport (GO:1902305) | 5.86 | 4 | SCN5A, SNTA1, SCN4B, CAV3 |
regulation of cardiac muscle cell contraction (GO:0086004) | 6.51 | 4 | CACNA1C, KCNJ2, SCN5A, ANK2 |
regulation of actin filament-based movement (GO:1903115) | 6.33 | 4 | KCNJ2, CACNA1C, SCN5A, ANK2 |
cellular metal ion homeostasis (GO:0006875) | 3.75 | 4 | KCNJ2, CACNA1C, CAV3, ANK2 |
cellular ion homeostasis (GO:0006873) | 3.57 | 4 | KCNJ2, CACNA1C, CAV3, ANK2 |
cellular cation homeostasis (GO:0030003) | 3.6 | 4 | KCNJ2, CACNA1C, CAV3, ANK2 |
cell communication (GO:0007154) | 3.04 | 4 | CACNA1C, AKAP9, SCN5A, ANK2 |
cellular chemical homeostasis (GO:0055082) | 3.4 | 4 | KCNJ2, CACNA1C, CAV3, ANK2 |
regulation of calcium ion import (GO:0090279) | 5.08 | 4 | CACNA1C, CALM1, CAV3, ANK2 |
response to oxygen-containing compound (GO:1901700) | 2.57 | 4 | AKAP9, KCNQ1, KCNE1, CALM1 |
regulation of calcium ion transmembrane transporter activity (GO:1901019) | 5.49 | 4 | CAV3, CALM1, ANK2, KCNE2 |
regulation of cellular component movement (GO:0051270) | 3.08 | 4 | KCNJ2, CACNA1C, SCN5A, ANK2 |
response to organonitrogen compound (GO:0010243) | 3.2 | 4 | AKAP9, CALM1, KCNE1, KCNQ1 |
negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.96 | 4 | KCNQ1, KCNE1, CAV3, KCNE2 |
membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915) | 8.34 | 4 | KCNQ1, KCNE1, KCNE2, KCNH2 |
ventricular cardiac muscle cell membrane repolarization (GO:0099625) | 8.34 | 4 | KCNQ1, KCNH2, KCNE1, KCNE2 |
negative regulation of cation channel activity (GO:2001258) | 6.26 | 4 | CALM1, KCNQ1, KCNE1, KCNE2 |
response to nitrogen compound (GO:1901698) | 3.12 | 4 | AKAP9, KCNE1, CALM1, KCNQ1 |
cellular response to cAMP (GO:0071320) | 5.82 | 3 | AKAP9, KCNQ1, KCNE1 |
regulation of phosphate metabolic process (GO:0019220) | 2.35 | 3 | AKAP9, CALM1, CAV3 |
phosphorylation (GO:0016310) | 2.63 | 3 | AKAP9, KCNH2, CALM1 |
negative regulation of cellular metabolic process (GO:0031324) | 2.01 | 3 | SNTA1, CALM1, CAV3 |
regulation of sequestering of calcium ion (GO:0051282) | 5.07 | 3 | CACNA1C, CALM1, ANK2 |
cellular response to drug (GO:0035690) | 5.48 | 3 | KCNH2, KCNQ1, KCNE2 |
calcium ion homeostasis (GO:0055074) | 3.97 | 3 | CACNA1C, CAV3, ANK2 |
second-messenger-mediated signaling (GO:0019932) | 4.65 | 3 | CACNA1C, CALM1, ANK2 |
potassium ion import (GO:0010107) | 6.4 | 3 | KCNJ2, KCNJ5, KCNE2 |
response to purine-containing compound (GO:0014074) | 4.67 | 3 | AKAP9, KCNQ1, KCNE1 |
cell communication involved in cardiac conduction (GO:0086065) | 6.73 | 3 | CACNA1C, SCN5A, ANK2 |
carbohydrate metabolic process (GO:0005975) | 3.26 | 3 | CALM1, KCNE1, ALG10 |
signal transduction by protein phosphorylation (GO:0023014) | 3.79 | 3 | AKAP9, KCNH2, CALM1 |
regulation of protein localization (GO:0032880) | 2.88 | 3 | CACNA1C, KCNE1, CAV3 |
divalent inorganic cation homeostasis (GO:0072507) | 3.9 | 3 | CACNA1C, CAV3, ANK2 |
negative regulation of protein metabolic process (GO:0051248) | 2.82 | 3 | SNTA1, CALM1, CAV3 |
cellular divalent inorganic cation homeostasis (GO:0072503) | 3.96 | 3 | CACNA1C, CAV3, ANK2 |
regulation of signal transduction (GO:0009966) | 1.84 | 3 | CALM1, CAV3, KCNE2 |
divalent metal ion transport (GO:0070838) | 4.15 | 3 | KCNJ2, CACNA1C, ANK2 |
positive regulation of protein modification process (GO:0031401) | 2.7 | 3 | AKAP9, CALM1, CAV3 |
cellular response to organic substance (GO:0071310) | 2.78 | 3 | AKAP9, KCNQ1, KCNE1 |
animal organ development (GO:0048513) | 2.53 | 3 | CACNA1C, CAV3, KCNE2 |
positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 6.36 | 3 | CALM1, ANK2, KCNE2 |
regulation of cardiac muscle cell action potential (GO:0098901) | 6.78 | 3 | CACNA1C, CAV3, ANK2 |
positive regulation of calcium ion transmembrane transport (GO:1904427) | 5.69 | 3 | CALM1, ANK2, KCNE2 |
regulation of receptor activity (GO:0010469) | 4.98 | 3 | CALM1, CAV3, KCNE2 |
response to organophosphorus (GO:0046683) | 4.79 | 3 | AKAP9, KCNQ1, KCNE1 |
regulation of calcium ion transport into cytosol (GO:0010522) | 5.23 | 3 | CACNA1C, CALM1, ANK2 |
cellular response to endogenous stimulus (GO:0071495) | 3.33 | 3 | AKAP9, KCNQ1, KCNE1 |
protein phosphorylation (GO:0006468) | 2.89 | 3 | AKAP9, KCNH2, CALM1 |
cellular component assembly (GO:0022607) | 2.14 | 3 | KCNJ2, CAV3, ANK2 |
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881) | 6.9 | 3 | CACNA1C, CALM1, ANK2 |
negative regulation of delayed rectifier potassium channel activity (GO:1902260) | 7.53 | 3 | KCNQ1, KCNE1, KCNE2 |
calcium-mediated signaling (GO:0019722) | 5.24 | 3 | CACNA1C, CALM1, ANK2 |
cellular calcium ion homeostasis (GO:0006874) | 4.01 | 3 | CACNA1C, CAV3, ANK2 |
regulation of catalytic activity (GO:0050790) | 1.97 | 3 | AKAP9, CALM1, CAV3 |
regulation of phosphorus metabolic process (GO:0051174) | 2.35 | 3 | AKAP9, CALM1, CAV3 |
response to cAMP (GO:0051591) | 5.08 | 3 | AKAP9, KCNQ1, KCNE1 |
single-organism carbohydrate metabolic process (GO:0044723) | 3.42 | 3 | CALM1, KCNE1, ALG10 |
negative regulation of voltage-gated potassium channel activity (GO:1903817) | 7.53 | 3 | KCNQ1, KCNE1, KCNE2 |
regulation of phosphorylation (GO:0042325) | 2.5 | 3 | AKAP9, CALM1, CAV3 |
cellular response to oxygen-containing compound (GO:1901701) | 3.22 | 3 | AKAP9, KCNQ1, KCNE1 |
negative regulation of cellular protein metabolic process (GO:0032269) | 2.88 | 3 | SNTA1, CALM1, CAV3 |
regulation of protein phosphorylation (GO:0001932) | 2.57 | 3 | AKAP9, CALM1, CAV3 |
divalent inorganic cation transport (GO:0072511) | 4.13 | 3 | KCNJ2, CACNA1C, ANK2 |
vesicle-mediated transport (GO:0016192) | 2.72 | 3 | CALM1, CAV3, ANK2 |
positive regulation of calcium ion transport (GO:0051928) | 5.06 | 3 | CALM1, ANK2, KCNE2 |
cellular response to organic cyclic compound (GO:0071407) | 3.93 | 3 | AKAP9, KCNQ1, KCNE1 |
regulation of release of sequestered calcium ion into cytosol (GO:0051279) | 5.44 | 3 | CACNA1C, CALM1, ANK2 |
cellular response to nitrogen compound (GO:1901699) | 3.79 | 3 | AKAP9, KCNQ1, KCNE1 |
response to drug (GO:0042493) | 3.71 | 3 | KCNQ1, KCNH2, KCNE2 |
cellular response to organonitrogen compound (GO:0071417) | 3.87 | 3 | AKAP9, KCNQ1, KCNE1 |
phosphate-containing compound metabolic process (GO:0006796) | 2.16 | 3 | AKAP9, KCNH2, CALM1 |
regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 6.68 | 3 | CACNA1C, CALM1, ANK2 |
regulation of delayed rectifier potassium channel activity (GO:1902259) | 6.84 | 3 | KCNQ1, KCNE1, KCNE2 |
phosphorus metabolic process (GO:0006793) | 2.15 | 3 | AKAP9, KCNH2, CALM1 |
system development (GO:0048731) | 2.92 | 3 | CACNA1C, KCNQ1, ANK2 |
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.59 | 3 | CACNA1C, CALM1, ANK2 |
negative regulation of protein modification process (GO:0031400) | 3.4 | 3 | SNTA1, CALM1, CAV3 |
positive regulation of cation channel activity (GO:2001259) | 6.17 | 3 | CALM1, ANK2, KCNE2 |
protein localization (GO:0008104) | 2.36 | 2 | CAV3, ANK2 |
regulation of secretion (GO:0051046) | 3.2 | 2 | CACNA1C, KCNQ1 |
G2/M transition of mitotic cell cycle (GO:0000086) | 4.84 | 2 | AKAP9, CALM1 |
negative regulation of response to stimulus (GO:0048585) | 2.52 | 2 | CALM1, CAV3 |
membrane organization (GO:0061024) | 3.04 | 2 | CAV3, ANK2 |
plasma membrane organization (GO:0007009) | 4.8 | 2 | CAV3, ANK2 |
potassium ion homeostasis (GO:0055075) | 6.84 | 2 | KCNJ2, KCNH2 |
membrane depolarization during AV node cell action potential (GO:0086045) | 8.34 | 2 | CACNA1C, SCN5A |
membrane depolarization during SA node cell action potential (GO:0086046) | 8.34 | 2 | SCN5A, ANK2 |
establishment of protein localization to plasma membrane (GO:0090002) | 5.2 | 2 | CAV3, ANK2 |
protein localization to plasma membrane (GO:0072659) | 5.29 | 2 | CAV3, ANK2 |
regulation of cardiac conduction (GO:1903779) | 5.57 | 2 | CALM1, ANK2 |
negative regulation of signal transduction (GO:0009968) | 2.75 | 2 | CALM1, CAV3 |
cellular macromolecule localization (GO:0070727) | 3.1 | 2 | CAV3, ANK2 |
MAPK cascade (GO:0000165) | 3.91 | 2 | AKAP9, CALM1 |
response to mechanical stimulus (GO:0009612) | 4.41 | 2 | KCNJ2, CAV3 |
macromolecule localization (GO:0033036) | 2.34 | 2 | CAV3, ANK2 |
regulation of cell proliferation (GO:0042127) | 2.41 | 2 | SCN5A, CAV3 |
sensory perception of sound (GO:0007605) | 4.82 | 2 | KCNQ1, KCNE1 |
regulation of protein kinase activity (GO:0045859) | 3.15 | 2 | CALM1, CAV3 |
sensory perception (GO:0007600) | 2.93 | 2 | KCNQ1, KCNE1 |
establishment of protein localization (GO:0045184) | 2.53 | 2 | CAV3, ANK2 |
regulation of proteolysis (GO:0030162) | 3.2 | 2 | CAV3, KCNE2 |
protein localization to membrane (GO:0072657) | 3.95 | 2 | CAV3, ANK2 |
response to metal ion (GO:0010038) | 3.91 | 2 | CALM1, SCN5A |
response to inorganic substance (GO:0010035) | 3.56 | 2 | CALM1, SCN5A |
positive regulation of phosphorylation (GO:0042327) | 2.9 | 2 | AKAP9, CALM1 |
negative regulation of phosphorylation (GO:0042326) | 3.7 | 2 | CALM1, CAV3 |
response to external stimulus (GO:0009605) | 2.55 | 2 | KCNJ2, CAV3 |
positive regulation of cytosolic calcium ion concentration (GO:0007204) | 4.56 | 2 | CACNA1C, CAV3 |
positive regulation of heart contraction (GO:0045823) | 6.15 | 2 | KCNQ1, SCN5A |
positive regulation of catabolic process (GO:0009896) | 3.94 | 2 | CAV3, KCNE2 |
regulation of catabolic process (GO:0009894) | 3.52 | 2 | CAV3, KCNE2 |
microtubule cytoskeleton organization (GO:0000226) | 4.13 | 2 | AKAP9, CAV3 |
regulation of protein transport (GO:0051223) | 3.12 | 2 | CACNA1C, KCNE1 |
regulation of oxidoreductase activity (GO:0051341) | 5.27 | 2 | CALM1, CAV3 |
protein localization to cell periphery (GO:1990778) | 4.91 | 2 | CAV3, ANK2 |
positive regulation of GTPase activity (GO:0043547) | 3.28 | 2 | AKAP9, CALM1 |
positive regulation of hydrolase activity (GO:0051345) | 2.91 | 2 | AKAP9, CALM1 |
regulation of kinase activity (GO:0043549) | 3.07 | 2 | CALM1, CAV3 |
regulation of immune system process (GO:0002682) | 2.5 | 2 | KCNQ1, CALM1 |
regulation of sodium ion transmembrane transporter activity (GO:2000649) | 6.09 | 2 | SCN4B, CAV3 |
anatomical structure formation involved in morphogenesis (GO:0048646) | 3.01 | 2 | CAV3, ANK2 |
regulation of establishment of protein localization (GO:0070201) | 3.02 | 2 | CACNA1C, KCNE1 |
lipid metabolic process (GO:0006629) | 2.68 | 2 | CAV3, ALG10 |
sensory perception of mechanical stimulus (GO:0050954) | 4.79 | 2 | KCNQ1, KCNE1 |
regulation of monooxygenase activity (GO:0032768) | 5.69 | 2 | CALM1, CAV3 |
regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372) | 7.94 | 2 | KCNQ1, SCN5A |
regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373) | 7.78 | 2 | SCN5A, CAV3 |
sodium ion transport (GO:0006814) | 4.75 | 2 | SCN5A, SCN4B |
positive regulation of blood circulation (GO:1903524) | 5.16 | 2 | KCNQ1, SCN5A |
macromolecule glycosylation (GO:0043413) | 4.2 | 2 | KCNE1, ALG10 |
single-organism membrane organization (GO:0044802) | 3.19 | 2 | CAV3, ANK2 |
negative regulation of intracellular signal transduction (GO:1902532) | 3.63 | 2 | CALM1, CAV3 |
regulation of postsynaptic membrane potential (GO:0060078) | 5.72 | 2 | SCN5A, SCN4B |
regulation of intracellular signal transduction (GO:1902531) | 2.31 | 2 | CALM1, CAV3 |
neurological system process (GO:0050877) | 2.64 | 2 | KCNQ1, KCNE1 |
regulation of hydrolase activity (GO:0051336) | 2.53 | 2 | AKAP9, CALM1 |
potassium ion export across plasma membrane (GO:0097623) | 9.04 | 2 | KCNH2, KCNQ1 |
detection of stimulus (GO:0051606) | 3.22 | 2 | CALM1, CAV3 |
sensory organ development (GO:0007423) | 4.82 | 2 | CACNA1C, KCNE2 |
regulation of response to stress (GO:0080134) | 2.53 | 2 | KCNQ1, CAV3 |
regulation of transferase activity (GO:0051338) | 2.88 | 2 | CALM1, CAV3 |
positive regulation of protein catabolic process (GO:0045732) | 4.18 | 2 | CAV3, KCNE2 |
positive regulation of phosphorus metabolic process (GO:0010562) | 2.78 | 2 | AKAP9, CALM1 |
regulation of response to external stimulus (GO:0032101) | 3.06 | 2 | CALM1, KCNQ1 |
negative regulation of cellular component organization (GO:0051129) | 3.35 | 2 | KCNE1, CAV3 |
regulation of cellular component organization (GO:0051128) | 2.01 | 2 | KCNE1, CAV3 |
regulation of cellular protein localization (GO:1903827) | 3.43 | 2 | KCNE1, CAV3 |
negative regulation of signaling (GO:0023057) | 2.65 | 2 | CALM1, CAV3 |
regulation of protein catabolic process (GO:0042176) | 3.83 | 2 | CAV3, KCNE2 |
negative regulation of cell communication (GO:0010648) | 2.66 | 2 | CALM1, CAV3 |
response to calcium ion (GO:0051592) | 4.98 | 2 | CALM1, SCN5A |
anatomical structure morphogenesis (GO:0009653) | 2.53 | 2 | CACNA1C, SCN5A |
regulation of GTPase activity (GO:0043087) | 3.21 | 2 | AKAP9, CALM1 |
positive regulation of catalytic activity (GO:0043085) | 2.4 | 2 | AKAP9, CALM1 |
negative regulation of cellular protein localization (GO:1903828) | 4.82 | 2 | KCNE1, CAV3 |
regulation of cellular catabolic process (GO:0031329) | 3.83 | 2 | CAV3, KCNE2 |
positive regulation of multicellular organismal process (GO:0051240) | 2.49 | 2 | KCNQ1, SCN5A |
negative regulation of phosphorus metabolic process (GO:0010563) | 3.45 | 2 | CALM1, CAV3 |
positive regulation of sodium ion transport (GO:0010765) | 6.23 | 2 | SCN5A, SCN4B |
positive regulation of cell proliferation (GO:0008284) | 3.01 | 2 | SCN5A, CAV3 |
organelle organization (GO:0006996) | 2.02 | 2 | AKAP9, CAV3 |
positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 6.96 | 2 | AKAP9, ANK2 |
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052) | 4.6 | 2 | CAV3, KCNE2 |
positive regulation of cellular catabolic process (GO:0031331) | 4.15 | 2 | CAV3, KCNE2 |
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050) | 4.32 | 2 | CAV3, KCNE2 |
cellular lipid metabolic process (GO:0044255) | 2.92 | 2 | CAV3, ALG10 |
T-tubule organization (GO:0033292) | 8.63 | 2 | CAV3, ANK2 |
AV node cell action potential (GO:0086016) | 8.34 | 2 | SCN5A, SCN4B |
SA node cell action potential (GO:0086015) | 7.94 | 2 | SCN5A, ANK2 |
atrial cardiac muscle cell action potential (GO:0086014) | 7.65 | 2 | KCNQ1, ANK2 |
regulation of membrane depolarization (GO:0003254) | 6.04 | 2 | SCN5A, CAV3 |
calcium ion transport (GO:0006816) | 4.33 | 2 | CACNA1C, ANK2 |
establishment of protein localization to membrane (GO:0090150) | 4.14 | 2 | CAV3, ANK2 |
positive regulation of proteolysis (GO:0045862) | 3.86 | 2 | CAV3, KCNE2 |
cell cycle G2/M phase transition (GO:0044839) | 4.82 | 2 | AKAP9, CALM1 |
mitotic cell cycle process (GO:1903047) | 3.12 | 2 | AKAP9, CALM1 |
cell cycle phase transition (GO:0044770) | 4.24 | 2 | AKAP9, CALM1 |
mitotic cell cycle phase transition (GO:0044772) | 4.27 | 2 | AKAP9, CALM1 |
cell cycle process (GO:0022402) | 2.75 | 2 | AKAP9, CALM1 |
regulation of protein serine/threonine kinase activity (GO:0071900) | 3.58 | 2 | CALM1, CAV3 |
protein glycosylation (GO:0006486) | 4.2 | 2 | KCNE1, ALG10 |
sodium ion transmembrane transport (GO:0035725) | 5.23 | 2 | SCN5A, SCN4B |
positive regulation of heart rate (GO:0010460) | 6.59 | 2 | KCNQ1, SCN5A |
regulation of cellular protein catabolic process (GO:1903362) | 4.23 | 2 | CAV3, KCNE2 |
regulation of voltage-gated calcium channel activity (GO:1901385) | 6.59 | 2 | CALM1, KCNE2 |
regulation of gene expression (GO:0010468) | 1.37 | 2 | KCNQ1, ANK2 |
positive regulation of cellular protein catabolic process (GO:1903364) | 4.52 | 2 | CAV3, KCNE2 |
positive regulation of phosphate metabolic process (GO:0045937) | 2.78 | 2 | AKAP9, CALM1 |
negative regulation of phosphate metabolic process (GO:0045936) | 3.45 | 2 | CALM1, CAV3 |
cellular protein localization (GO:0034613) | 3.11 | 2 | CAV3, ANK2 |
glycosylation (GO:0070085) | 4.16 | 2 | KCNE1, ALG10 |
monovalent inorganic cation homeostasis (GO:0055067) | 4.93 | 2 | KCNJ2, KCNH2 |
establishment of localization in cell (GO:0051649) | 2.47 | 2 | CACNA1C, ANK2 |
cellular localization (GO:0051641) | 2.32 | 2 | CAV3, ANK2 |
regulation of nitric-oxide synthase activity (GO:0050999) | 5.9 | 2 | CALM1, CAV3 |
response to abiotic stimulus (GO:0009628) | 2.8 | 2 | KCNJ2, CAV3 |
microtubule-based process (GO:0007017) | 3.54 | 2 | AKAP9, CAV3 |
cytoskeleton organization (GO:0007010) | 3.22 | 2 | AKAP9, CAV3 |
regulation of cytosolic calcium ion concentration (GO:0051480) | 4.41 | 2 | CACNA1C, CAV3 |
negative regulation of calcium ion transport (GO:0051926) | 5.84 | 2 | CALM1, CAV3 |
single-organism organelle organization (GO:1902589) | 2.68 | 2 | AKAP9, CAV3 |
negative regulation of protein phosphorylation (GO:0001933) | 3.79 | 2 | CALM1, CAV3 |
single-organism cellular localization (GO:1902580) | 3.16 | 2 | CAV3, ANK2 |
positive regulation of protein phosphorylation (GO:0001934) | 2.95 | 2 | AKAP9, CALM1 |